Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds
Martin Nimczick, Michael Decker
ChemMedChem (2015) Vol. 10, Iss. 5, pp. 773-786
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
Piyoosh Sharma, Pavan Srivastava, Ankit Seth, et al.
Progress in Neurobiology (2018) Vol. 174, pp. 53-89
Closed Access | Times Cited: 285
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
Gemma Navarro, Paula Morales, Carmen Rodríguez‐Cueto, et al.
Frontiers in Neuroscience (2016) Vol. 10
Open Access | Times Cited: 133
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update
Paula Morales, Laura Hernández‐Folgado, Pilar Goya, et al.
Expert Opinion on Therapeutic Patents (2016) Vol. 26, Iss. 7, pp. 843-856
Closed Access | Times Cited: 65
2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts
Amy Hauck Newman, Francisco O. Battiti, Alessandro Bonifazi
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 5, pp. 1779-1797
Open Access | Times Cited: 62
Structure–Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles
Dominik Dolles, Matthias Hoffmann, Sandra Gunesch, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 4, pp. 1646-1663
Closed Access | Times Cited: 57
Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo
Matthias Scheiner, Dominik Dolles, Sandra Gunesch, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 20, pp. 9078-9102
Open Access | Times Cited: 43
Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors
Szabolcs Dvorácskó, Attila Keresztes, Adriano Mollica, et al.
European Journal of Medicinal Chemistry (2019) Vol. 178, pp. 571-588
Open Access | Times Cited: 30
Allosteric Modulation of Cannabinoid Receptor 1—Current Challenges and Future Opportunities
Szymon Hryhorowicz, Marta Kaczmarek-Ryś, Angelika Andrzejewska-Romanowska, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5874-5874
Open Access | Times Cited: 30
Novel approaches and current challenges with targeting the endocannabinoid system
Paula Morales, Nadine Jagerovic
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 8, pp. 917-930
Open Access | Times Cited: 30
Aminobenzimidazoles and Structural Isomers as Templates for Dual‐Acting Butyrylcholinesterase Inhibitors and hCB2R Ligands To Combat Neurodegenerative Disorders
Dominik Dolles, Martin Nimczick, Matthias Scheiner, et al.
ChemMedChem (2015) Vol. 11, Iss. 12, pp. 1270-1283
Closed Access | Times Cited: 32
Role of N-Arachidonoyl-Serotonin (AA-5-HT) in Sleep-Wake Cycle Architecture, Sleep Homeostasis, and Neurotransmitters Regulation
Eric Murillo-Rodrı́guez, Vincenzo Di Marzo, Sérgio Machado, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 30
The First Photochromic Affinity Switch for the Human Cannabinoid Receptor 2
Dominik Dolles, Andrea Straßer, Hans‐Joachim Wittmann, et al.
Advanced Therapeutics (2018) Vol. 1, Iss. 1
Open Access | Times Cited: 24
Multitarget Ligands that Comprise Opioid/Nonopioid Pharmacophores for Pain Management: Current State of the Science
Émile Breault, Michael Desgagné, Jolien De Neve, et al.
Pharmacological Research (2024), pp. 107408-107408
Open Access | Times Cited: 2
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
Barbara Vuić, Tina Milos, Lucija Tudor, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3000-3000
Open Access | Times Cited: 12
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes
Filippo Basagni, Michela Rosini, Michael Decker
ChemMedChem (2020) Vol. 15, Iss. 15, pp. 1374-1389
Open Access | Times Cited: 16
Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases
Juan A. Páez, Nuria E. Campillo
Current Medicinal Chemistry (2018) Vol. 26, Iss. 18, pp. 3300-3340
Open Access | Times Cited: 18
A New Class of Synthetic Flavonolignan-Like Dimers: Still Few Molecules, but with Attractive Properties
Valeria Romanucci, Giovanni Di Fabio, Armando Zarrelli
Molecules (2018) Vol. 24, Iss. 1, pp. 108-108
Open Access | Times Cited: 17
Continuing challenges in targeting oligomeric GPCR-based drugs
Joaquín Botta, Julia Appelhans, Peter J. McCormick
Progress in molecular biology and translational science (2020), pp. 213-245
Closed Access | Times Cited: 14
Multitarget Anti-Alzheimer Hybrid Compounds
Diego Muñoz‐Torrero
Elsevier eBooks (2017), pp. 167-192
Closed Access | Times Cited: 13
The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome
Antoni Cortés, Verònica Casadó-Anguera, Estefanía Moreno, et al.
Advances in pharmacology (2019), pp. 37-78
Closed Access | Times Cited: 11
Strategies for targeting cell surface proteins using multivalent conjugates and chemical biology
Shivani Sachdev, Chino C. Cabalteja, Ross W. Cheloha
Methods in cell biology (2021), pp. 205-222
Open Access | Times Cited: 9
Testosterone and its dimers alter tRNA morphology
P. Chanphai, Daniel Agudelo, A.R. Vesper, et al.
Journal of Pharmaceutical and Biomedical Analysis (2016) Vol. 134, pp. 269-274
Closed Access | Times Cited: 8
Dual-Acting Compounds Acting as Receptor Ligands and Enzyme Inhibitors
Dominik Dolles, Michael Decker
Elsevier eBooks (2017), pp. 137-165
Closed Access | Times Cited: 7
Special Issue: “Molecules against Alzheimer”
Michael Decker, Diego Muñoz‐Torrero
Molecules (2016) Vol. 21, Iss. 12, pp. 1736-1736
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top